Clinical and immunological features of pemphigus relapse.

CONCLUSION: mcPV shows transitions in clinical phenotype and autoantibody profile at relapse. At least 1mg/kg/day of prednisolone, especially for mcPV cases, and prudent tapering around 0·1mg/kg may lead to better outcomes. This article is protected by copyright. All rights reserved. PMID: 30585310 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30585310?dopt=Abstract

Source: The British Journal of Dermatology - December 26, 2018 Category: Dermatology Authors: Ujiie I, Ujiie H, Iwata H, Shimizu H Tags: Br J Dermatol Source Type: research